NFX-backed Pepper Bio emerges from stealth with tools to hone in on complex diseases
There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have rebounded to only about 2.5% in 2020, up from a low of 1.6% in 2019. Not to mention the fact that drugs that fail in clinical trials don’t actually help people who need new treatments. With a…
Comments Off on NFX-backed Pepper Bio emerges from stealth with tools to hone in on complex diseases
October 15, 2021